H.R. 3691 would reauthorize programs for residential treatment of pregnant and postpartum women. The bill also would require the Substance Abuse and Mental Health Services Administration (SAMHSA) to establish a pilot program to award grants to support programs that treat substance abuse in pregnant and postpartum women. Additionally, H.R. 3691 would reduce amounts authorized to be appropriated for existing activities related to bioterrorism and public health emergencies at the Centers for Disease Control and Prevention (CDC). Assuming appropriation actions consistent with the bill, CBO estimates that implementing H.R. 3691 would have a net discretionary cost of $65 million over the 2017-2021 period.
Pay-as-you-go procedures do not apply because enacting H.R. 3691 would not affect direct spending or revenues. CBO estimates that enacting H.R. 3691 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2027.
H.R. 3691 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.
